Abstract
The long-term treatment of angina pectoris (AP) with isosorbide dinitrate (ISDN), in slow-release and rapid-release form, has become accepted practice [13, 18, 20, 21], in spite of the first-pass effect [27, 28]. The action of this organic nitrate, like that of nitroglycerin, is to decrease the tone of both venous and arterial vessels. The resulting reduction of both the preload and the afterload leads to a reduction of the left ventricular (LV) oxygen requirement [1, 9, 11, 12, 15, 22, 23, 24]. It has been shown that ISDN, as well as isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN) are to be regarded as effective vasodilating agents, although of different potency [6, 8, 10, 14, 16, 17, 30, 32, 33, 35]. The major problem in therapeutic use of ISDN is that its rate of metabolism is subject to large individual variations, so that the amount of metabolites produced and the amount of unmetab-olized substance remaining are difficult to predict. Thus, the magnitude and duration of the effect of ISDN are linked with the presence of three substances exhibiting different pharmacodynamics [3, 4, 5, 26, 27, 28, 29, 31, 34].
A part of this study with 5 patients had been published previously in Med. Welt Bd.32/Heft 14a (1981)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aborelius M, Jecerof H, Malm A, Malmberg RO (1968) Acute effect of nitroglycerin on haemodynamics of angina pectoris. Br Heart J 30:407
Abrams J (1980) Nitroglycerin and long-acting nitrates. N Engl J Med 302:1234
Abshagen U, Spoerl-Radun S, Betzien G, Kaufmann B, Endele R(1981) Pharmakokinetik, Wirkung und Verträglichkeit von Isosorbiddinitrat und Isosorbid-5-Mononitrat bei gesunden Versuchspersonen. Med Welt 32:508
Abshagen U, Spoerl-Radun S (1981) First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man. Eur J Clin Pharmacol 19:423–429
Abshagen U, Betzien G, Endele R, Kaufmann B (1981) Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate. Eur J Clin Pharmacol 21:269–275
Assinder DF, Chasseaud LF, Taylor T (1977) Plasma isosorbide dinitrate concentrations in human subjects after administration of standard and sustained-release formulations. J Pharm Sci 66:775
Biamino G, Oeff M, Andresen D, Lichey HJ, Prokein E, Arntz R, Leitner E v, Schroeder R (1981) Haemodynamische Effekte von Isosorbid-5-Mononitrat unter Ruhe- und Belastungsbedingungen bei Patienten mit schwerer Angina pectoris. Med Welt 32:535
Bogaert MG, Rosseel MT (1972) Vascular effects of the dinitrate and mononitrate esters of isosorbide, isomannide and isoidide. Naunyn-Schmiedebergs Arch Pharmacol 275:339
Burggraf GW, Parker JO (1974) Left ventricular volume changes after amyl nitrite and nitroglycerin in man as measured by ultrasound. Circulation 49:136
Chasseaud LF, Down WH, Grundy RK (1975) Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood human subjects. Eur J Clin Pharmacol 8:157
Chatterjee K, Pamley WW, Swan HJ (1973) Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation 48:684
Cohn PE, Maddox D, Holman BL, Epstein SE (1977) Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol 39:672
Danahy DT, Aronow WS (1977) Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use. Circulation 56:205
Danahy DT, Burwell DT, Aronow WS, Prakash R (1977) Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate. Circulation 55:381
DeMaria A, Vismara L, Auditore K, Amsterdam EA, Zellis R, Mason DT (1974) Disturbances of cardiac rhythm and conduction induced by exercise. Diagnostic, prognostic and therapeutic implications. Am J Med 57:574
Dietz AJ Jr (1967) The biotransformation of isosorbide dinitrate in dogs and humans. Biochem Pharmacol 16:1447
Down WH, Chasseaud LF (1978) 2. Internationales Nitrat-Symposium, Berlin 1978 — “The metabolism of isosorbide dinitrate” (Abstr). Herz 3:206
Franciosa FA, Cohn JN (1980) Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol 45:648
Isbary J, Doering W, Wauer B, Greding H, Koenig E (1981) Haemodynamische Veränderungen in Ruhe und während Belastung nach 20 mg Isosorbid-5-Mononitrat bei Patienten mit koronarer Herzerkrankung. Med Welt 32:530
Kaltenbach M, Becker HJ (1979) Nitrate in der Therapie der koronaren Herzkrankheit. Dtsch Med Wochenschr 104:1723
Lee G, Mason DT, DeMaria AN (1978) Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Am J Cardiol 41:82
Mason DT, Braunwald E (1965) The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm. Circulation 32:755
Mason DT, Zelis R, Amsterdam EA (1971) Actions of the nitrites on the peripheral circulation and myocardial oxygen consumption: significance in the relief of angina pectoris. Chest 59:296
Mason DT, Awan NA, DeMaria A, Lee G, Amsterdam EA (1980) Cardiocirculatory effects of nitrates in the treatment of clinical congestive heart failure. In: Rudolph W, Schrey A (eds) Nitrate II. Urban und Schwarzenberg, p206
Mehmel HC, Ruffmann K, Schwarz F, Manthey J, Kuebler W (1981) Die Wirkung von Isosor-bid-5-Mononitrat (IS-5-MN) auf die linksventrikuläre Haemodynamik. Med Welt 32:527
Michel D (1970) Der Einfluß von Metaboliten des Isosorbid-Dinitrats auf das Belastungs-EKG bei Koronarinsuffizienz. Herz-Kreisl 8:444
Needleman Ph, Lang S, Johnson E (1972) Organic nitrates: Relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 181:489
Needleman Ph (1976) Organic nitrate metabolism1,2. Ann Rev Pharmacol 16:81
Orr J, Klein G, Shaar SF (1978) Plasma concentrations of isosorbide dinitrate and two major metabolites following oral administration of two formulations of isosorbide dinitrate tablets. Can J Pharm Sci 2:45
Seidel F, Michel D (1980) “3rd Int. Symp. Nitrates, Monte-Carlo”. Abstract 13
Shane SJ, Iazzetta JJ, Chisholm AW, Berka JF, Leung D (1978) Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man. Br J Clin Pharmacol 6:37
Sisenwine SF, Ruelius HW (1971) Plasma concentrations and urinary excretion of isosorbide dinitrate and its metabolites in the dog. J Pharmacol Exp Ther 176:296
Spoerl-Radun S, Betzien G, Kaufmann B, Liede V, Abshagen U (1980) Effects and pharmacokinetics of isosorbide dinitrate in normal man. Eur J Clin Pharmacol 18:237
Stauch M, Grewe N (1979) Die Wirkung von Isosorbiddinitrat, Isosorbid-2- und -5-Mononitrat auf das Belastungs-EKG und auf die Haemodynamik während Vorhofstimulation bei Patienten mit Angina pectoris. Z Kardiol 68:687
Wendt RL (1972) Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide. J Pharmacol Exp Ther 180:732
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Biamino, G. et al. (1985). Hemodynamic Effects of Isosorbide-5-Mononitrate in Patients with Coronary Artery Disease, at Rest and Under Exercise. In: Cohn, J.N., Rittinghausen, R. (eds) Mononitrates. International Boehringer Mannheim Symposia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70234-1_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-70234-1_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-15107-4
Online ISBN: 978-3-642-70234-1
eBook Packages: Springer Book Archive